Home Investment Portfolio DLVR Therapeutics DLVR Therapeutics Innovation Type: Therapeutics Cancer Type: Liver Funding Stage: Proof of Concept Fund: Compass Rose Novel nanoparticle delivery technology Related news There are currently no news items related to this portfolio company. CONNECT WITH FACIT Learn more about how we are driving made-in-Ontario oncology innovations reach the market. Name: Email: Message: Topic: GeneralFundingInvesting